New Two-Pronged attack on breast cancer in the liver
NCT ID NCT06875128
Summary
This study is for people with breast cancer that has spread mainly to the liver. It is testing if a two-step treatment is better than standard drugs alone. First, a special procedure delivers high-dose chemotherapy directly to the liver. Then, patients receive standard chemotherapy pills or infusions. Researchers want to see if this combined approach is safe and better at controlling the cancer in the liver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER IN THE LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Ohio State University, Stefanie Spielman Comprehensive Breast Center
RECRUITINGColumbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.